Hauguel-de Mouzon S. Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy. Am J Physiol Endocrinol Metab 303: E832-E840, 2012. First published July 17, 2012; doi:10.1152/ajpendo.00002.2012.-Changes in adipose tissue metabolism are central to adaptation of whole body energy homeostasis to pregnancy. To gain insight into the molecular mechanisms supporting tissue remodeling, we have characterized the longitudinal changes of the adipose transcriptome in human pregnancy. Healthy nonobese women recruited pregravid were followed in early (8 -12 wk) and in late (36 -38 wk) pregnancy. Adipose tissue biopsies were obtained in the fasting state from the gluteal depot. The adipose transcriptome was examined via whole genome DNA microarray. Expression of immune-related genes and extracellular matrix components was measured using real-time RT-PCR. Adipose mass, adipocyte size, and cell number increased in late pregnancy compared with pregravid measurements (P Ͻ 0.001) but remained unchanged in early pregnancy. The adipose transcriptome evolved during pregnancy with 10 -15% of genes being differently expressed compared with pregravid. Functional gene cluster analysis revealed that the early molecular changes affected immune responses, angiogenesis, matrix remodeling, and lipid biosynthesis. Increased expression of macrophage markers (CD68, CD14, and the mannose-6 phosphate receptor) emphasized the recruitment of the immune network in both early and late pregnancy. The TLR4/NF-B signaling pathway was enhanced specifically in relation to inflammatory adipokines and chemokines genes. We conclude that early recruitment of metabolic and immune molecular networks precedes the appearance of pregnancy-related physiological changes in adipose tissue. This biphasic pattern suggests that physiological inflammation is an early step preceding the development of insulin resistance, which peaks in late pregnancy.
Maternal body composition reflects homeostatic changes.
EXTENSIVE MODIFICATIONS OF MATERNAL BODY COMPOSITION take place during pregnancy. Total adipose mass and maternal blood volume increase significantly, whereas there is little change in maternal lean tissue mass (28, 32) . The dynamic role of adipose tissue in the metabolic adaptations to pregnancy is highlighted by longitudinal changes in adipose tissue mass. There is a wide individual variation in fat mass accumulation that can range from Ϫ2 to Ͼ10 kg/woman depending on race, ethnicity, and nutritional and metabolic factors (30, 40) . In lean women, the total gain in fat mass represents about 30% of gestational weight gain (22) , but women with pre-ravid obesity usually gain less total weight than lean women (18) . In uncomplicated pregnancies with appropriate weight gain, most fat deposition occurs during the second trimester and remains constant until term (22, 54) . The mechanisms underlying the early adjustments for increased fat deposition have yet to be defined in either normal or metabolically compromised pregnancies.
Storage and endocrine function. The changes in body composition during pregnancy are driven primarily by adaptations of maternal metabolic homeostasis. The ultimate goal of pregnancy-induced metabolic changes is to meet the high-energy demands of fetal development. Glucose, the primary energy fuel used by fetal tissues, needs to be readily available for transplacental transfer, whereas maternal tissues can rely on other energy substrates, such as lipids (3) . The adaptations of lipid metabolism follow a well-described biphasic pattern. The first half of pregnancy is centered on storing maternal energy as adipose tissue triglycerides, whereas in late pregnancy the stored lipids are mobilized to be used by peripheral tissues and in preparation for lactation (25) . These sequential adaptations are facilitated by modifications of insulin secretion and action. In early pregnancy, the higher insulin sensitivity facilitates cellular anabolism through activation of lipogenesis. Then, insulin resistance develops progressively to culminate in the third trimester (7, 43) . Insulin resistance allows adipose tissue to mobilize the lipids stored earlier and skeletal muscle to utilize less glucose. These changes in maternal metabolic homeostasis result in increased circulating levels of insulin and triglycerides in late pregnancy (23) . In addition to alterations in its capacity for energy storage, the endocrine function of adipose tissue also evolves during pregnancy. The synthesis and plasma concentration of leptin and adiponectin, two major adipokines, exhibit longitudinal changes parallel to those of insulin sensitivity. Whereas leptin concentrations increase early, there is a significant decrease in plasma adiponectin during the third trimester (9, 26) . The longitudinal modifications of adipokines in healthy pregnancy are further enhanced in the context of pregnancy with diabetes and obesity (10, 24) .
Remodeling. White adipose tissue displays a remarkable flexibility, with an important and reversible capacity for expansion throughout adult life. Remodeling of the adipose tissue mass requires the integration of cellular mechanisms to support an increase in size and/or number of adipocytes. The turnover of fat cells is highly sensitive to variations in the metabolic and hormonal milieu, i.e., development, aging, diet, or metabolic disorders occurring throughout the lifespan (16, 33, 52) . In obese individuals, the enlargement of adipose tissue requires active turnover of adipocytes with chronic inflammation elicited by accumulation of macrophages in the stromal vascular compartment (21, 60) . Previously, we have shown that macrophage infiltration and increased adipocyte death contribute to inflammation in pregnant women with pregravid obesity (2, 12) .
The aim of this study was to characterize the mechanisms responsible for the increase in adipose tissue mass during normal human pregnancy. We have conducted a longitudinal analysis beginning before and continuing throughout pregnancy to characterize the morphological and molecular traits of the adipose tissue in nonobese women. We show that molecular changes supporting remodeling of gluteal adipose tissue precede phenotypic changes in fat accretion and lipid metabolism that culminate in late pregnancy.
METHODS

Subjects.
Eleven women with singleton pregnancies were recruited prepregnancy (P) and followed up longitudinally in both early (E; 8 -12 wk) and late pregnancy (L; 36 -38 wk). The protocol was approved by the Institutional Review Board and Clinical Research Unit Scientific Review Committee at Case Western Reserve University. Volunteers gave their written informed consent, in accordance with the MetroHealth Medical Center (Cleveland, OH) Guidelines for the Protection of Human Subjects.
Metabolic and anthropometric measurements. Anthropometric measurements and body composition were estimated using hydrodensitometry, as described previously (8, 27) . Insulin sensitivity was measured with the euglycemic hyperinsulinemic clamp technique (7). Plasma was separated by centrifugation and kept frozen at Ϫ20°C until being assayed. Glucose was assessed by the glucose oxidase method (YSI, Yellow Springs, OH). Plasma insulin was measured using the sensitive human insulin radioimmunoassay kit (Linco Research, St. Charles, MO). The limit of sensitivity for the insulin assay is 0.2 U/ml, with intra-assay coefficients of variation (CV) of 4. Adipose tissue analysis: measurements of cell number and size. Biopsies of adipose tissue (800 -1,200 mg) from 11 women were obtained via liposuction of the subcutaneous gluteal depot at each time point (P, E, and L). One fragment of tissue was fixed immediately for immunohistochemistry, one fragment was snap-frozen in liquid nitrogen for RNA processing, and the remaining tissue was processed for collagenase digestion. After digestion with 1 mg/ml collagenase (Worthington Biochemical, Lakewood, NJ) for 45 min at 37°C, the mixture was filtered through a 100-m gauze mesh. The infranatant was removed, and the floating layer of adipocytes was brought up to 10 ml for counting and size measurements. Adipocyte diameter was determined using a ϫ10 W. F. objective lens containing a ruler (Olympus BH-2 microscope; Olympus, Hiroshima, Japan). Numbers from 10 fields were averaged, and cellularity was defined as the number of adipocytes per gram of digested adipose tissue (44) .
Immunohistochemistry. Adipose tissue sections were fixed in 10% formalin and included in paraffin. Five-micrometer sections were counterstained using eosin and hematoxylin gill II (Sigma-Aldrich). Digitized images were obtained using a Nikon E600 microscope equipped with a DXM200 camera.
Protein expression. Lysates of whole adipose tissue were prepared using 10 mM Tris-NaCl, pH 8, and lysis buffer with 1% Triton and protease inhibitors (Sigma-Aldrich). Protein lysates (2-200 g/ml) were separated by SDS-PAGE (7% polyacrylamide gels) and immunoblotted or directly blotted to nitrocellulose for microfiltration (Hoefer). HL-60 whole cell lysate (Santa Cruz, CA) was used as positive control. Primary antibodies against GAPDH (1:3,000), glucose transporter 5 (1:500), lipoprotein lipase (LPL; 1:500), and adiponectin (1:500) were from Abcam. Actin (1:2,000), CCAAT/enhancer-binding protein (C/EBP) (1:500), and Toll-like receptor 4 (TLR4) (1:300) were from Santa Cruz Biotechnology; lipolysaccharide-binding protein (1:500) was from Origene Technologies. Detection was performed using anti-mouse or anti-rabbit HRP-coupled secondary antibodies (1:5,000) and ECL Plus Western blot chemiluminescence reagents (Amersham, GE Heathcare Sciences). Signal intensity was quantitated by gel doc imager (Bio-Rad).
Gene expression analysis. Total RNA was isolated from intact adipose tissue using the Trizol (Invitrogen, Carlsbad, CA) extraction method. Gene expression was analyzed via whole genome microarray profiling, using U133 Affymetrix arrays and platforms as described (41) . Selection of the significantly modified transcripts was performed by a multistep filter strategy. Among the genes that showed an absolute call of present according to MAS 5.0 algorithm, we selected the genes with a difference in signal detection of Ն4.5 times the average background minus the scaled noise. The hybridization intensities of significantly modified genes were examined by hierarchic cluster analysis with Gene-Spring GX (Agilent Technologies, Santa Clara, CA) and Treeview software (free). The genes that satisfied these criteria were then selected on the basis of a fold change Ͼ1.52 or Ͻ1.52 that was consistent in at least two comparisons. Genes that related to energy metabolism were identified according to the function of their putative encoded proteins from public databases. (IPA; Ingenuity Systems, Redwood City, CA). Changes in gene expression were validated by real-time PCR (Roche Thermocycler; Roche Applied Science, Indianapolis, IN) with LightCycler FastStart DNA SYBR Green 1 master mix and primers from Integrated DNA Technologies (Coralville, IA). Primers for specific target sequences were designed within the 3= coding region of the genes.
Statistics. All values are presented as means Ϯ SE. Differences between dependent variables were examined with one-way or twoway repeated-measures analysis of variance. Significant mean differences among the three time points were identified with Fisher's protected least significant difference post hoc test. The data were analyzed using the StatView II statistical package (Abacus Concepts, Berkeley, CA). Statistical significance was set at P Ͻ 0.05.
RESULTS
Longitudinal phenotypic and metabolic changes. Longitudinal measurements were performed prepregnancy (P) and in both early (8 -12 wk) (E) and late pregnancy (36 -38 wk) (L). Metabolic and anthropometric parameters are listed in Table 1 . Both plasma cholesterol and triglyceride concentrations were increased in L, whereas plasma free fatty acids were decreased compared with pregravid measurements. Insulin sensitivity decreased significantly in L compared with both E and P. Leptin concentrations increased significantly in E and remained elevated until L. Measurements of body composition showed that total body fat mass was increased in late gestation (P Ͻ 0.001; Fig. 1 ). An increase in the size and number of adipocytes was observed in L compared with pregravid but was not detected at early stages (P Ͻ 0.001; Fig. 1 ).
Molecular characteristics of adipose tissue. Using whole genome microarray analysis, the adipose tissue transcriptome, encompassing 12,897 Ϯ 417 genes, remained quantitatively stable during pregnancy, with 13,510 Ϯ 197 genes expressed during E and 13,097 Ϯ 298 genes expressed during L. Principal component analysis revealed a large overlap in expression pattern between the pregravid, E, and L stages (Fig. 2) . The genes differentially expressed in E (n ϭ 1,286) and L (n ϭ 1,111) represented 10 -15% of the adipose tissue transcriptome. Comparison of global gene expression also revealed a distinct expression pattern in E and L (Fig. 2) . Analysis of differentially modified genes based on their biological function indicated that 65% of pregnancy-associated changes were related to tissue remodeling (39%) and lipid metabolism (26%) ( Tables 2 and 3 and Fig. 3) . Genes involved in tissue remodeling were further separated into three main functional categories: mediators of the immune response, extracellular matrix components, and angiogenic factors (Fig. 3) . Marked changes in genes regulating pathways for the inflammatory response and metabolism were noted in E compared with P. Innate immune responses elicited through the TLR4/NF-B signaling pathway led to early increases in gene and protein expression of TLR4 as well as TNF␣, IL-6, and small chemokines of the C-X-CL family (Fig. 4, A and B) . Metabolic genes facilitating lipid accumulation through adipocyte differentiation and lipogenesis were most activated in E (Fig. 5, A and B, and Table 4 ). High expression of transcription factors of the forkhead box O (FOXO), peroxisome proliferator-activated receptor-␥ (PPAR␥), cAMP response element-binding protein, and sterol regulatory element-binding protein families were indicative of adipocyte differentiation. Increased VLDL receptor and LDL-related protein 1, fatty acid synthase, acetyl-CoA carboxylase, and stearoyl-CoA desaturase catalyzing fatty acid uptake, synthesis, and elongation were evidence of active lipogenesis. Extracellular matrix components with structural (elastin, collagen) and adhesive properties (laminin, fibronectin) were activated predominantly in E and included upregulation of metalloproteinases to enhance tissue plasticity through the release of insulin-like growth factor I (IGF-I). The concomitant activation of several angiogenic factors [VEGF, TGF␤, angiotensin, fibroblast growth factor receptor 2 (FGFR2)] suggested that neovascularization was associated with matrix remodeling (Table 2 ).
DISCUSSION
Our study demonstrates an enlargement of adipose tissue during pregnancy, combining a higher cell number (hyperplasia) and a larger cell size (hypertrophy). This is in agreement with data for lower body depots in women (17, 50) but differs from the mechanisms described in obesity with hypertrophy occurring prior to hyperplasia. Hyperplasic growth appears to be genetically regulated, whereas hypertrophy is more nutritionally regulated (29) . Growth is also dependent on each depot-unique gene signature, which defines the proliferation of adipocyte precursors (57) . The longitudinal changes were characterized in the gluteal subcutaneous adipose depot. This depot is preferentially expanding in pregnancy (18) , accessible to biopsy, and more prone to inflammatory changes than mesenteric or omental visceral depots (19) . Further studies performed at visceral sites will help to achieve a global picture of adipose tissue changes.
Expansion and remodeling. Our study reveals that adaptations of adipose tissue to healthy pregnancy develop in a temporal manner, with an array of molecular changes preceding the anthropometric expansion of adipose mass. Adipose tissue enlargement relies on molecular cross-talks between distinct cell types of the stromal-vascular fraction surrounding the adipocytes (45, 48) . In agreement with this concept, our study suggests that pregnancy-induced adipose tissue expansion involves a combination of signaling pathways shared by preadipocytes and immune and endothelial cells (Fig. 6) .
The flexibility of the cellular matrix surrounding the adipocytes plays a central role in the regulation of tissue expandability. Remodeling of extracellular matrix components is accelerated in a number of metabolic diseases that are associated with changes in the hormonal milieu (12, 48) . Increases in metalloproteinases, fibronectin, and laminin accelerate preadipocyte differentiation in hypertrophic adipose tissue of obese individuals (20, 47) . On the other hand, angiogenesis, which is also required for adipose tissue remodeling, may be facilitated by metalloproteinases and collagenases (11) . VEGF-A and its most important functional partner, angiopoietin, are essential for initiation of the angiogenic program (59, 61) . Hence, the combined increase in growth factors (IGF-II, FGFR2) and angiogenic factors (VEGF, TGF␤) is in line with the contribution of angiogenic mechanisms to the overall adipose tissue remodeling of early pregnancy (49) .
The microenvironment surrounding the adipocyte may also be shaped by the production of adipokines that exert both paracrine and endocrine effects. TNF␣ and IL-6 exhibit increased expres- sion in both the early and late stages of pregnancy, and therefore, they may regulate the expression of other genes that contribute to the negative action of insulin (21) . The increase in leptin receptor expression is in agreement with a stimulatory role of leptin on angiogenesis, whereas the lack of leptin gene regulation is consistent with the rise in plasma leptin levels in pregnancy being contributed mainly by the placenta (34) . Adipocyte biology. The 29% increase in fat mass measured in late pregnancy was associated with active cellular remodeling of adipose tissue. The activation of endothelial LPL suggested accelerated hydrolysis of circulating triglycerides into free fatty acids available for cellular uptake. Our findings bring support to a crucial role of LPL for increasing lipid storage in adipose tissue of pregnant rats (42) . The upregulation of many other genes directly affecting lipogenesis and adipocyte differentiation indicated that those pathways are recruited early in pregnancy to enhance lipid storage in both mature and newly synthesized adipocytes. The forkhead transcription factor FOXO1 isoform, a master regulator of energy homeostasis in white adipose tissue, was one of the early induced genes. Activation of FOXO1 may contribute to the regulation of adipocyte size in response to excessive calorie intake (36, 37) . Because FOXO1 is a direct PPAR␥ ligand, it may also contribute to the regulation of adipose size and adipogenic pathways (15, 53) . The nutrient-sensitive genes C/EBP␣, sterol regulatory element-binding protein-1, and PPAR␥, which are mandatory regulators of both early and late programs of adipose differentiation (6, 14, 56) , were also activated early in pregnancy. As a whole, the changes in the metabolic machinery indicated that enhanced adipocyte storage and increased differentiation of new adipose cells were initiated at early pregnancy stages. These findings emphasize the notion that the molecular mechanisms of the adipogenic process come into place well before the appearance of classical phenotypic markers. Our data also suggest a similarity between the mechanisms of adipose tissue physiological expansion in pregnancy and pathological expansion in obesity. One example is the early increase in secreted frizzled-related protein 1, an endogenous modulator of Wnt/␤-catenin signaling that peaks in patients with mild obesity and gradually falls in morbidly obese subjects (Table 2 and Ref. 31) .
Inflammation. Signs of molecular inflammation were detected in adipose tissue from early stages throughout the end of pregnancy. The functional cluster of genes related to immune regulation represented 30% of all modified genes in pregnancy compared with the pregravid state (Fig. 2) . Increased expression of the macrophage markers CD14, CD68, HLA-DR, and HLA-DQ and the mannose receptor was in line with a recent report of inflammatory changes in adipose tissue in mice in late pregnancy (60) . mRNA of TLR4 and downstream modulators were increased in early pregnancy. TLR4 belongs to a family of membrane receptors first recruited in innate sensing through binding of the lipid A moiety of lipopolysaccharide released from gram-negative bacteria (46) .
The environmental factors that may trigger the recruitment of innate immune pathways in early pregnancy are not known. The activation of TLR4 signal transduction has been proposed as a molecular link between diet-induced obesity and increased insulin resistance (5, 54). Nutritional changes through either maternal hyperphagia or dysphagia are potential candidates to impact adipose tissue receptors and function (4) . Along this line, changes in microbiota have been documented in relation to gestational weight gain and may impact TLR4 signaling in pregnancy (13) . Bacterial recognition by the serum amyloid A (SAA) receptor CD36 may also initiate inflammation in response to fat supply (5, 59) . The acute-phase proteins of the SAA family are markers of low-grade inflammation and obesity and promote endothelial remodeling partly through TLR4-mediated pathways (39, 58, 1) .
Conclusion. Whereas substantial literature has established inflammation as an obligatory component of adipose tissue remodeling in obesity and other diseases, this report is the first indication of recruitment of inflammatory pathways in healthy human pregnancy. Enhancement of adipose immune response preceded the appearance of maternal phenotypic changes in body composition and insulin action. This biphasic pattern reveals physiological inflammation as an early step toward the development of physiological insulin resistance, which peaks later in pregnancy.
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